
    
      To investigate the efficacy of ranibizumab intravitreal injections-driven by achieving vision
      acuity stabilization compared to combination with laser photocoagulation in Chinese patients
      with visual impairment in ME due to BRVO.

      The result of the trial will be used to support new therapy in the BRVO in China.
    
  